Dipartimento di Medicina Clinica e Chirurgia
Naples, 80131, Italy
NCT Number: NCT04840966
The Flavor test has been developed and validated by our group to assess retro-nasal olfactory performances.
The original flavor test has been simplified, with the great advantage to be self-administrable for COVID-19 patients in isolation, without any risk to health professionals.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Naples, 80131, Italy
Smell and taste dysfunctions (STDs) are symptoms associated with COVID-19 syndrome, even if their incidence is still uncertain and variable. In this study, the effects of SARS-CoV-2 infection on chemosensory function have been investigated using both a self-reporting questionnaire on smell and flavor perception, and a simplified flavor test. A total of 111 subjects (19 hospitalized [HOS] and 37 home-isolated [HI] COVID-19 patients, and 55 healthy controls [CTRL]) were enrolled in the study. The flavor test used consists in the self-administration of four solution with a pure olfactory stimulus (coffee), a mixed olfactory-trigeminal stimulus (peppermint), and a complex chemical mixture (banana).
After SARS-CoV-2 infection, HOS and HI patients reported similar frequency of STDs, with a significant reduction of both smell and flavor self-estimated perception.
The aromas of the Flavor test were recognized by HI and HOS COVID-19 patients similarly to CTRL, however the intensity of the perceived aromas was significantly lower in patients compared to controls.
This suggests that a chemosensory impairment is present after SARS-CoV-2 infection, and the modified "flavor test" could be a novel self-administering objective screening test to assess STDs in COVID-19 patients.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A simplified self-administrable flavor test has been proposted to all the enrolled subjects
Questionnaire to score subjective chemosensory function (smell and flavor) before and after COVID-19 using a 0-10 scale with 0 corresponding to "no smell/flavor perception" and 10 corresponding to "excellent smell/flavor perception".
Time frame: Apr, 2020- Jan, 2021
To assess qualitative flavor perception
Time frame: Apr, 2020- Jan, 2021
To assess quantitative flavor perception
Time frame: Apr, 2020- Jan, 2021
To compare results of the test with self-assessed flavor and smell perception
Federico II University
Other
Simplified Flavor Test for Self-administation in COVID-19 Positive Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04466982
Anosmia, COVID-19
Cambridge, United Kingdom
View Trial DetailsNCT04495816
Anosmia, COVID-19
New York, United States
View Trial DetailsNCT04789499
Ageusia, Anosmia
St Louis, Missouri, United States
View Trial DetailsNCT04406584
Anosmia, COVID-19
San Diego, California, United States
View Trial Details